Cetuximab in the treatment of metastatic renal cell carcinoma
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Škach Jiří | cs |
dc.contributor.author | Hromádka Peter | cs |
dc.date.accessioned | 2018-09-25T12:18:19Z | |
dc.date.available | 2018-09-25T12:18:19Z | |
dc.date.issued | 2017 | cs |
dc.format.extent | 2 | cs |
dc.identifier.issn | 0862-8947 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/31796 | |
dc.language.iso | cze | cs |
dc.publisher | Panax | cs |
dc.publisher.city | Praha | cs |
dc.relation.ispartofseries | 0 | cs |
dc.subject | colorectal carcinoma | cs |
dc.subject | metastases | cs |
dc.subject | targeted therapy | cs |
dc.title | Cetuximab in the treatment of metastatic renal cell carcinoma | en |
dc.title | Cetuximab v léčbě metastatického renálního karcinomu-kazuistiky | cs |
local.citation.epage | 345-346 | cs |
local.citation.spage | 345-346 | cs |
local.identifier.publikace | 5265 | |
local.relation.issue | 4 | cs |